Hepatology Research 

TL;DR: The results indicate that TTV would be responsible for a part of acute and chronic liver disease of unknown etiology.

TL;DR: The cumulative survival rates of newly registered patients in the 12th to 17th follow‐up surveys conducted between 1992 and 2003 were calculated for each histological type (HCC, ICC, and combined HCC and ICC) and stratified by background factors and treatment.

TL;DR: Population‐based data in the USA indicate low application rate of HCC potentially curative therapy and marked regional differences and Insulin resistance syndrome manifesting as obesity and diabetes is emerging as a risk factor for HCC in theUSA and may operate through the formation of non‐alcoholic fatty liver disease (NAFLD); however, its effect on the current trend remains unclear.

TL;DR: The assessment criteria for sarcopenia in liver disease proposed by the Japan Society of Hepatology (JSH) are summarized in this article, where the authors present the assessment criteria to the best of their knowledge.

TL;DR: The 3rd version of Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence‐based medicine, which was published in October 2013 in Japanese.